内心キムラ病の最初の報告
Andrew D Wisneski1, Jamal S Rana2, Eugene Fan3
1Division of Cardiothoracic Surgery, Department of Surgery, University of California San Francisco, San Francisco, California, USA.
JACC. Case reports
|September 6, 2025
まとめ
この報告は 珍しい炎症性疾患である 胸内キムラ病の 最初の症例の詳細です 心臓の切除は成功し,フォローアップでは再発は観察されなかった.
科学分野:
- 心臓病科
- 病理学について
- 珍しい 病気
背景:
- キムラ病は珍しい炎症性疾患で,通常は頭部と首に皮膚の下の結節が起きます.
- キムラ病の心臓内関与は極めてまれで,事前に記録された症例はありません.
- このケースは 心臓に現れる キムラ病の 最初の例です
研究 の 目的:
- 心臓内部のキムラ病の 最初の症例を報告する
- 診断の難しさと 治療の成功を強調する
- キムラ病の潜在的外症状の理解に貢献する.
主な方法:
- 57歳の女性患者に 心臓発作と呼吸不全の症状が出ました
- エコーカルディオグラフィーは右心室の流出管を阻害する重要な質量 (3cm) を特定しました.
- 腫瘍の切除と肺弁の置換を施し,その後,診断のための組織病理学的分析を行った.
主要な成果:
- 病理学的な検査で 切除された塊がキムラ病だと確認された
- 患者は 補助的なステロイドや放射線治療なしで 手術を受けた.
- エコーカルディオグラフィを含む1年間の積極的な監視では,疾患の再発の証拠は示されなかった.
結論:
- この症例は 心臓内キムラ病を 独立した臨床実体として確立しています
- 手術による切除は,心内キムラ病の有効な第一治療法である.
- キムラ病の潜在的再発をモニタリングするには,長期の監視が不可欠です.
関連する概念動画
01:25Cardiomyopathy I: Introduction and Classification
49
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
49
01:21Myocarditis I: Introduction
28
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
54
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
54
01:23Rheumatic Heart Disease I: Introduction
38
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
38
01:27Myocarditis II: Clinical Features and Diagnostic Tests
20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21